科华生物：公司重视市值管理的工作

Core Viewpoint - The company emphasizes the importance of market capitalization management and acknowledges that stock prices are influenced by various factors beyond intrinsic value, including macroeconomic conditions, industry trends, and investor preferences [1] Group 1: Company Strategy - The company is committed to continuous high-quality development as the foundation for market capitalization management [1] - The company will focus on its core business and implement multiple measures to enhance operational efficiency and actively develop its business [1] - The company aims to improve its overall strength and intrinsic value through these efforts [1] Group 2: Compliance and Disclosure - The company will diligently implement its valuation enhancement plan and strictly adhere to information disclosure obligations as per relevant regulations [1]